Page last updated: 2024-10-20

phosphorylethanolamine and Brain Disorders

phosphorylethanolamine has been researched along with Brain Disorders in 2 studies

phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.

Research Excerpts

ExcerptRelevanceReference
"Pyridoxine-sensitive seizures characterize severe forms of infantile HPP."1.46Neuromuscular features of hypophosphatasia. ( Fonta, C; Salles, JP, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fonta, C1
Salles, JP1
Mandal, PK1
Akolkar, H1

Other Studies

2 other studies available for phosphorylethanolamine and Brain Disorders

ArticleYear
Neuromuscular features of hypophosphatasia.
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2017, Volume: 24, Issue:5S2

    Topics: Adult; Alkaline Phosphatase; Animals; Biomarkers; Brain Diseases; Chronic Pain; Disease Models, Anim

2017
A new experimental approach and signal processing scheme for the detection and quantitation of ³¹P brain neurochemicals from in vivo MRS studies using dual tuned (¹H/³¹P) head coil.
    Biochemical and biophysical research communications, 2011, Aug-26, Volume: 412, Issue:2

    Topics: Brain; Brain Chemistry; Brain Diseases; Ethanolamines; Humans; Hydrogen; Magnetic Resonance Spectros

2011